ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,022.21
      -0.58%
      US Tech 100
      17,063.60
      -1.05%
      Dow Jones
      37,753.31
      -0.12%
      Brent Oil
      87.035
      0.06%
      Bitcoin
      61,911.71
      1.03%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Akari Therapeutics PLC (AKTX)

      7. Akari Therapeutics PLC (AKTX) News

      AKTX Akari Therapeutics PLC

      1.1212
      -0.0343 (-2.97%)
      Apr 17 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Akari Therapeutics PLC AKTX NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.0343 -2.97% 1.1212 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      1.10 1.0775 1.2383 1.1212 1.1555
      more quote information »

      Recent News

      Date Time Source Heading
      4/17/20248:00IHNWFeaturedGlucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring
      3/15/202412:53PRNUSKuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to..
      3/11/202417:25EDGAR2Form 425 - Prospectuses and communications, business..
      3/11/202417:24EDGAR2Form 8-K - Current report
      3/05/202416:57EDGAR2Form 425 - Prospectuses and communications, business..
      3/05/202408:34EDGAR2Form 425 - Prospectuses and communications, business..
      3/05/202408:28EDGAR2Form 8-K - Current report
      1/09/202417:25EDGAR2Form D - Notice of Exempt Offering of Securities
      1/04/202412:34EDGAR2Form SC 13D/A - General statement of acquisition of..
      1/02/202419:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/02/202419:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/02/202418:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/02/202418:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/02/202416:30EDGAR2Form 8-K - Current report
      12/01/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/16/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/27/202316:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      10/20/202317:00EDGAR2Form SC 13D/A - General statement of acquisition of..
      10/20/202316:29EDGAR2Form POS AM - Post-Effective amendments for registration..
      10/20/202316:28EDGAR2Form POS AM - Post-Effective amendments for registration..
      10/20/202316:23EDGAR2Form F-3 - Registration statement by foreign private issuers
      10/12/202316:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
      9/29/202308:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/21/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/05/202309:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/18/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/15/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/02/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/27/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/25/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/19/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/13/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/11/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/07/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/06/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/05/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      6/30/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      5/16/202316:05GLOBEAspira Women’s Health Names Torsten Hombeck as Chief..

      Your Recent History

      NASDAQ
      AKTX
      Akari Therapeutics
      Delayed Upgrade Clock